Amador Bioscience Nabs $60M Series B+ Round Posted by dumbcapital | Dec 31, 2021 | Raises and Exits, Uncategorized | 0 | PLEASANTON, CA, Amador Bioscience, a global translational sciences and clinical pharmacology CRO, has raised a $60 million Series B+ financing.